ID: ALA2393341

Max Phase: Preclinical

Molecular Formula: C12H15N3O

Molecular Weight: 217.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc2c(NCCN)ccnc2c1

Standard InChI:  InChI=1S/C12H15N3O/c1-16-9-2-3-10-11(15-7-5-13)4-6-14-12(10)8-9/h2-4,6,8H,5,7,13H2,1H3,(H,14,15)

Standard InChI Key:  UZYGRPKEIPMAGS-UHFFFAOYSA-N

Associated Targets(non-human)

Ferriprotoporphyrin IX 165 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 217.27Molecular Weight (Monoisotopic): 217.1215AlogP: 1.61#Rotatable Bonds: 4
Polar Surface Area: 60.17Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.65CX LogP: 0.65CX LogD: -2.46
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.82Np Likeness Score: -0.91

References

1. Nsumiwa S, Kuter D, Wittlin S, Chibale K, Egan TJ..  (2013)  Structure-activity relationships for ferriprotoporphyrin IX association and β-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods.,  21  (13): [PMID:23669191] [10.1016/j.bmc.2013.04.040]

Source